Diabetes rate doubles to 800 million adults, but over half are untreated
The total number of adults living with type 1 or type 2 diabetes in the world has surpassed 800 million, according to new Imperial-led research.
Could a ‘DNA diet’ help to reduce health risks linked to high blood sugar?
A UK trial has found a DNA-tailored diet could help manage blood glucose and reduce risk of progressing to type 2 diabetes in high-risk individuals.
Q&A: Does diabetes mean worse outcomes for cancer patients?
Diabetes is a known risk factor for developing cancer, but could it also predict how cancer patients respond to treatment?
Imperial researchers work with European partners to combat diet-related diseases
The CoDiet project plans to combat diet-related diseases through innovative diet-monitoring technologies and personalised nutrition.
£2 million awarded for development of beta cell implant for type 1 diabetes
A leading researcher at Imperial College London has been awarded £2 million that will fund ground-breaking research into type 1 diabetes.
High blood caffeine levels may reduce body weight and type 2 diabetes risk
A high blood caffeine level may reduce the body weight a person carries and their risk of type 2 diabetes, according to research.
Audio
Podcast: Treating diabetes, boardroom diversity, and avoiding hangovers
In this edition: We meet a clinician investigating diabetes, find out how boardroom diversity benefits companies, and hope for a hangover cure.
COVID-19 mapper reveals symptom variation between countries and health status
Imperial research has unveiled how COVID-19 symptoms varied between country and health condition in 2020 in partnership with symptom mapper Healthily.
Scientists use graphene sheets to improve lab-on-chip diagnostic tests
Imperial College London researchers have improved an electronic sensor that can be used for fast detection of infectious diseases like COVID-19.
Feature
Working together to build a better heart
We are pleased to share that Professor Costanza Emanueli was re-awarded her position as British Heart Foundation (BHF) Chair of Cardiovascular Science
